相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease
Mark Lowenberg et al.
GASTROENTEROLOGY (2019)
Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target
Ben Kang et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2018)
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Dong Il Park et al.
INTESTINAL RESEARCH (2018)
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
Dong Il Park et al.
INTESTINAL RESEARCH (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment
Ben Kang et al.
JOURNAL OF CROHNS & COLITIS (2016)
Inflammatory Bowel Disease in Children and Adolescents
Michael J. Rosen et al.
JAMA PEDIATRICS (2015)
Comparison of Pyogenic Spondylitis and Tuberculous Spondylitis
Kyu Yeol Lee
ASIAN SPINE JOURNAL (2014)
Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population
Cândida Abreu et al.
Journal of Crohns & Colitis (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Spinal tuberculosis in children: Retrospective analysis of 124 patients
Myung-Sang Moon et al.
INDIAN JOURNAL OF ORTHOPAEDICS (2012)
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
Juan J. Gomez-Reino et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
LP Ormerod et al.
THORAX (2005)
Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept?
S Ehlers
CLINICAL INFECTIOUS DISEASES (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
Spinal tuberculosis (Pott's disease): its clinical presentation, surgical management, and outcome. A survey study on 694 patients
M Turgut
NEUROSURGICAL REVIEW (2001)